Gilead Sciences, Inc.GILDNASDAQ
Loading
Revenue Growth Under PressureDecelerating
Percentile Rank59
3Y CAGR-25.9%
5Y CAGR-31.0%
Year-over-Year Change
Year-over-year revenue growth rate
3Y CAGR
-25.9%/yr
Quarterly compound
5Y CAGR
-31.0%/yr
Recent acceleration
Percentile
P59
Within normal range
vs 5Y Ago
0.2x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | 2.01% |
| Q3 2025 | 9.72% |
| Q2 2025 | 6.21% |
| Q1 2025 | -11.92% |
| Q4 2024 | 0.32% |
| Q3 2024 | 8.51% |
| Q2 2024 | 3.99% |
| Q1 2024 | -6.02% |
| Q4 2023 | 0.91% |
| Q3 2023 | 6.83% |
| Q2 2023 | 3.89% |
| Q1 2023 | -14.03% |
| Q4 2022 | 4.93% |
| Q3 2022 | 12.49% |
| Q2 2022 | -5.01% |
| Q1 2022 | -9.03% |
| Q4 2021 | -2.39% |
| Q3 2021 | 19.37% |
| Q2 2021 | -3.21% |
| Q1 2021 | -13.45% |
| Q4 2020 | 12.83% |
| Q3 2020 | 27.88% |
| Q2 2020 | -7.30% |
| Q1 2020 | -5.63% |
| Q4 2019 | 4.91% |
| Q3 2019 | -1.42% |
| Q2 2019 | 7.65% |
| Q1 2019 | -8.87% |
| Q4 2018 | 3.56% |
| Q3 2018 | -0.92% |
| Q2 2018 | 11.01% |
| Q1 2018 | -14.47% |
| Q4 2017 | -8.65% |
| Q3 2017 | -8.81% |
| Q2 2017 | 9.78% |
| Q1 2017 | -11.13% |
| Q4 2016 | -2.40% |
| Q3 2016 | -3.55% |
| Q2 2016 | -0.23% |
| Q1 2016 | -8.37% |